ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,771Medicare Part D Prescriptions Filled, Including Refills

Rank: 199 out of 973

$424K Total Retail Price of All Prescriptions

Rank: 210 out of 973

348 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 323 323 1 2
WARFARIN SODIUM 305 283 2 10
LISINOPRIL 291 266 3 3
FUROSEMIDE 283 264 4 6
SIMVASTATIN 278 259 5 1
HYDROCODONE-ACETAMINOPHEN 232 189 S3 6 4
AMLODIPINE BESYLATE 192 180 7 7
METOPROLOL TARTRATE 179 176 8 13
METFORMIN HCL 162 158 9 8
ATENOLOL 155 135 10 16
CARVEDILOL 143 132 11 27
POLYETHYLENE GLYCOL 3350 142 139 12 36
BYSTOLIC 140 138 13 110
ATORVASTATIN CALCIUM 133 133 14 15
DIGOXIN 132 114 15 32
POTASSIUM CHLORIDE 129 122 16 9
SERTRALINE HCL 126 117 17 21
OMEPRAZOLE 122 110 18 5
LOSARTAN POTASSIUM 118 114 19 19
HYDROCHLOROTHIAZIDE 109 101 20 11
PREDNISONE 96 84 21 33
METOPROLOL SUCCINATE 96 96 21 17
ALENDRONATE SODIUM 93 77 23 24
PANTOPRAZOLE SODIUM 88 71 24 37
SPIRONOLACTONE-HCTZ 83 83 25 284
MIRTAZAPINE 83 83 25 43
NITROGLYCERIN PATCH 76 76 27 173
GABAPENTIN 75 75 28 12
ALLOPURINOL 74 74 29 29
TAMSULOSIN HCL 73 70 30 28
NEXIUM 69 56 31 30
CARBIDOPA-LEVODOPA 63 63 32 71
DIOVAN 60 60 33 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 51 34 25
AMITRIPTYLINE HCL 55 51 R 35 52
CRESTOR 55 52 35 34
FINASTERIDE 54 54 37 90
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 37 46
AVODART 53 53 39 218
PAROXETINE HCL 52 41 40 66
SPIRIVA 51 42 41 73
LEVOFLOXACIN 51 48 41 84
DILTIAZEM 24HR CD 51 51 41 104
SPIRONOLACTONE 50 50 44 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.